Compound ID | 329
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Description: | Cephalosporin-type |
| Institute where first reported: | Meiji Seika Kaisha (Meiji Seika Pharma., Japan) |
| Year first mentioned: | 1989 |
| Development status: | Experimental |